Market Recap Check: Travere Therapeutics Inc (TVTX)’s Positive Finish at 17.57, Up/Down 0.40

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Travere Therapeutics Inc (NASDAQ: TVTX) closed at $17.57 in the last session, up 0.40% from day before closing price of $17.50. In other words, the price has increased by $0.40 from its previous closing price. On the day, 1.94 million shares were traded. TVTX stock price reached its highest trading level at $18.56 during the session, while it also had its lowest trading level at $17.395.

Ratios:

We take a closer look at TVTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 1.71.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on October 21, 2024, Upgraded its rating to Overweight and sets its target price to $27 from $9 previously.

Guggenheim Upgraded its Neutral to Buy on September 09, 2024, while the target price for the stock was maintained at $25.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 04 ’24 when LYONS GARY A sold 40,000 shares for $14.73 per share. The transaction valued at 589,101 led to the insider holds 51,000 shares of the business.

GARY A LYONS bought 40,000 shares of TVTX for $546,000 on Oct 04 ’24. On Sep 30 ’24, another insider, Meckler Jeffrey A, who serves as the Director of the company, sold 40,000 shares for $14.06 each. As a result, the insider received 562,324 and left with 81,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1371336832 and an Enterprise Value of 1496332288. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.77. Its current Enterprise Value per Revenue stands at 7.355 whereas that against EBITDA is -6.268.

Stock Price History:

Over the past 52 weeks, TVTX has reached a high of $19.25, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 21.04%, while the 200-Day Moving Average is calculated to be 84.83%.

Shares Statistics:

According to the various share statistics, TVTX traded on average about 1.78M shares per day over the past 3-months and 1289220 shares per day over the past 10 days. A total of 78.05M shares are outstanding, with a floating share count of 76.87M. Insiders hold about 1.51% of the company’s shares, while institutions hold 114.00% stake in the company. Shares short for TVTX as of 1728950400 were 8107720 with a Short Ratio of 4.56, compared to 1726185600 on 8657111. Therefore, it implies a Short% of Shares Outstanding of 8107720 and a Short% of Float of 11.68.

Most Popular